United States · Bill · HR
H.R. 19 (116th)
Lower Costs, More Cures Act of 2019
Introduced
9 December 2019
Last action
19 December 2019 · Referred
Status
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Sponsors
Rep. Walden, Greg [R-OR-2], Rep. Brady, Kevin [R-TX-8], Rep. Foxx, Virginia [R-NC-5], Rep. Collins, Doug [R-GA-9], Rep. Burgess, Michael C. [R-TX-26], Rep. Nunes, Devin [R-CA-22], Rep. Walberg, Tim [R-MI-5], Rep. Sensenbrenner, F. James, Jr. [R-WI-5], Rep. Scalise, Steve [R-LA-1], Rep. Cheney, Liz [R-WY-At Large], Rep. Upton, Fred [R-MI-6], Rep. Shimkus, John [R-IL-15], Rep. Latta, Robert E. [R-OH-5], Rep. Guthrie, Brett [R-KY-2], Rep. McMorris Rodgers, Cathy [R-WA-5], Rep. Olson, Pete [R-TX-22], Rep. McKinley, David B. [R-WV-1], Rep. Kinzinger, Adam [R-IL-16], Rep. Griffith, H. Morgan [R-VA-9], Rep. Bilirakis, Gus M. [R-FL-12], Rep. Johnson, Bill [R-OH-6], Rep. Long, Billy [R-MO-7], Rep. Bucshon, Larry [R-IN-8], Rep. Flores, Bill [R-TX-17], Rep. Brooks, Susan W. [R-IN-5], Sen. Mullin, Markwayne [R-OK], Rep. Hudson, Richard [R-NC-8], Rep. Carter, Earl L. "Buddy" [R-GA-1], Rep. Gianforte, Greg [R-MT-At Large], Rep. Palmer, Gary J. [R-AL-6], Rep. Cole, Tom [R-OK-4], Rep. Williams, Roger [R-TX-25], Rep. Abraham, Ralph Lee [R-LA-5], Rep. Keller, Fred [R-PA-12], Rep. Rutherford, John H. [R-FL-5], Rep. Ferguson, A. Drew, IV [R-GA-3], Rep. Kustoff, David [R-TN-8], Denver Riggleman, Rep. Westerman, Bruce [R-AR-4], Rep. Graves, Garret [R-LA-6], Rep. LaMalfa, Doug [R-CA-1], Rep. Baird, James R. [R-IN-4], Rep. Huizenga, Bill [R-MI-4], Rep. Murphy, Gregory F. [R-NC-3], Rep. Conaway, K. Michael [R-TX-11], Rep. Allen, Rick W. [R-GA-12], Rep. Weber, Randy K. Sr. [R-TX-14], Rep. Newhouse, Dan [R-WA-4]
Subjects
Healthcare
Source updated
7 April 2025
Summary
Lower Costs, More Cures Act of 2019 This bill establishes and modifies several requirements to address prescription drug prices under Medicare, Medicaid, and other programs. The bill generally limits payment amounts for drugs and biologics under Medicare medical services, reduces cost-sharing under the Medicare prescription drug benefit, modifies certain authorities and requirements under the Medicaid Drug Rebate Program, revises provisions relating to regulatory approval and commercial availability of generics and biosimilars, and establishes several reporting requirements for drug manufacturers with respect to drug prices.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
9 December 2019
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
9 December 2019
Introduced
Introduced in House
Source: IntroReferral
9 December 2019
Introduced
Introduced in House
Source: IntroReferral
10 December 2019
Referred
Referred to the Subcommittee on Health.
Source: Committee
19 December 2019
Referred
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 9 December 2019 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 9 December 2019
Introduced in House (PDF)
Introduced in House · EN · 9 December 2019
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 9 December 2019
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Walden, Greg [R-OR-2] · R · Sponsor
- Rep. Brady, Kevin [R-TX-8] · R · Sponsor
- Rep. Foxx, Virginia [R-NC-5] · R · Sponsor
- Rep. Collins, Doug [R-GA-9] · R · Sponsor
- Rep. Burgess, Michael C. [R-TX-26] · R · Sponsor
- Rep. Nunes, Devin [R-CA-22] · R · Sponsor
- Rep. Walberg, Tim [R-MI-5] · R · Sponsor
- Rep. Sensenbrenner, F. James, Jr. [R-WI-5] · R · Sponsor
- Rep. Scalise, Steve [R-LA-1] · R · Sponsor
- Rep. Cheney, Liz [R-WY-At Large] · R · Sponsor
- Rep. Upton, Fred [R-MI-6] · R · Sponsor
- Rep. Shimkus, John [R-IL-15] · R · Sponsor
- Rep. Latta, Robert E. [R-OH-5] · R · Sponsor
- Rep. Guthrie, Brett [R-KY-2] · R · Sponsor
- Rep. McMorris Rodgers, Cathy [R-WA-5] · R · Sponsor
- Rep. Olson, Pete [R-TX-22] · R · Sponsor
- Rep. McKinley, David B. [R-WV-1] · R · Sponsor
- Rep. Kinzinger, Adam [R-IL-16] · R · Sponsor
- Rep. Griffith, H. Morgan [R-VA-9] · R · Sponsor
- Rep. Bilirakis, Gus M. [R-FL-12] · R · Sponsor
- Rep. Johnson, Bill [R-OH-6] · R · Sponsor
- Rep. Long, Billy [R-MO-7] · R · Sponsor
- Rep. Bucshon, Larry [R-IN-8] · R · Sponsor
- Rep. Flores, Bill [R-TX-17] · R · Sponsor
- Rep. Brooks, Susan W. [R-IN-5] · R · Sponsor
- Sen. Mullin, Markwayne [R-OK] · R · Sponsor
- Rep. Hudson, Richard [R-NC-8] · R · Sponsor
- Rep. Carter, Earl L. "Buddy" [R-GA-1] · R · Sponsor
- Rep. Gianforte, Greg [R-MT-At Large] · R · Sponsor
- Rep. Palmer, Gary J. [R-AL-6] · R · Sponsor
- Rep. Cole, Tom [R-OK-4] · R · Sponsor
- Rep. Williams, Roger [R-TX-25] · R · Sponsor
- Rep. Abraham, Ralph Lee [R-LA-5] · R · Sponsor
- Rep. Keller, Fred [R-PA-12] · R · Sponsor
- Rep. Rutherford, John H. [R-FL-5] · R · Sponsor
- Rep. Ferguson, A. Drew, IV [R-GA-3] · R · Sponsor
- Rep. Kustoff, David [R-TN-8] · R · Sponsor
- Denver Riggleman · R · Sponsor
- Rep. Westerman, Bruce [R-AR-4] · R · Sponsor
- Rep. Graves, Garret [R-LA-6] · R · Sponsor
- Rep. LaMalfa, Doug [R-CA-1] · R · Sponsor
- Rep. Baird, James R. [R-IN-4] · R · Sponsor
- Rep. Huizenga, Bill [R-MI-4] · R · Sponsor
- Rep. Murphy, Gregory F. [R-NC-3] · R · Sponsor
- Rep. Conaway, K. Michael [R-TX-11] · R · Sponsor
- Rep. Allen, Rick W. [R-GA-12] · R · Sponsor
- Rep. Weber, Randy K. Sr. [R-TX-14] · R · Sponsor
- Rep. Newhouse, Dan [R-WA-4] · R · Sponsor
Showing 48 of 151 sponsors and actors.
Related records
- related to ← BLOCKING Act of 2019
- related to ← CREATES Act of 2019
- related to ← Payment Commission Data Act of 2019
- related to ← Protecting Consumer Access to Generic Drugs Act of 2019
- related to ← Further Extension of Continuing Appropriations Act, 2021
- related to ← Orange Book Transparency Act of 2020
- related to ← A bill to amend titles XVIII and XIX of the Social Security Act to provide the Medicare Payment Advisory Commission and the Medicaid and CHIP Payment and Access Commission with access to certain drug payment information, including certain rebate information.
- related to ← Payment Commission Data Act of 2019
Showing 8 of 34 related records.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/19
- Open data entity: https://api.congress.gov/v3/bill/116/hr/19
- us · 116-hr-19 · source updated 7 April 2025